Sort
17,054 grants matching “genome editing”
University of Washington Center for Nuclear Organization and Function
$276,971Jay Ashok Shendure · University Of Washington · U54 · FY2019 · DK
Chemical Pathology of 5-aza-2'-deoxycytidine
$276,793Lawrence C Sowers · Loma Linda University · R01 · FY2007 · CA
MegaTALS: hyperspecific reagents for targeted gene modification and correction
$276,714Barry L. Stoddard · Fred Hutchinson Cancer Center · R01 · FY2022 · GM
Core C: Cell Phenotyping and Molecular Imaging Core
$276,502Jan M Skotheim · Stanford University · P01 · FY2022 · CA
Molecular control of calcium influx at the ER-plasma membrane junctions
$276,450Yubin Zhou · Texas A&M University Health Science Ctr · R01 · FY2014 · GM
Molecular control of calcium influx at the ER-plasma membrane junctions
$276,450Yubin Zhou · Texas A&M University Health Science Ctr · R01 · FY2017 · GM
Molecular control of calcium influx at the ER-plasma membrane junctions
$276,450Yubin Zhou · Texas A&M University Health Science Ctr · R01 · FY2018 · GM
Molecular control of calcium influx at the ER-plasma membrane junctions
$276,450Yubin Zhou · Texas A&M University Health Science Ctr · R01 · FY2016 · GM
Molecular control of calcium influx at the ER-plasma membrane junctions
$276,450Yubin Zhou · Texas A&M University Health Science Ctr · R01 · FY2015 · GM
Variation, Function, and Disease Supplement Program
$276,315Eric B Larson · Kaiser Foundation Research Institute · U01 · FY2018 · HG
Hepatitis B Clinical Research Network Clinical Center: Michigan - Hawaii Consortium
$276,228Anna Sf Lok · University Of Michigan At Ann Arbor · U01 · FY2017 · DK
Development of potent and safe CRISPR tools for in vivo gene editing using directed evolution
$276,000Shannon Marie Miller · Scripps Research Institute, The · R21 · FY2024 · EB
Mechanisms of HTLV-I Tax-mediated NF-kB activation
$275,940Edward W Harhaj · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2018 · CA
Develop combinatorial non-viral and viral CRISPR delivery for lung diseases
$275,792Guang-Ping Gao · Univ Of Massachusetts Med Sch Worcester · UG3 · FY2019 · HL
Translational development of novel CRISPR approach to treat genomic duplications
$275,651Monkol Lek · Myofinity Biosciences Inc · R41 · FY2023 · AR
Core F: Biomarker
$275,625Celeste Marie Karch · Washington University · P30 · FY2022 · AG
Core F: Biomarker
$275,625Celeste Marie Karch · Washington University · P30 · FY2024 · AG
Project 6: Microbial Communities that Bioremediate Chemical Mixtures
$275,563Lisa Alvarez-Cohen · University Of California Berkeley · P42 · FY2019 · ES
Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors
$275,486Jessica Jiyeong Lin · Massachusetts General Hospital · R01 · FY2019 · CA
Project 4: Targeting Glutamine Metabolism in Colorectal Cancer Harboring PIK3CA Mutations
$275,312Zhenghe Wang · Case Western Reserve University · P50 · FY2020 · CA
PROJECT 1
$275,130Reuben S Harris · University Of Texas Hlth Science Center · P01 · FY2022 · CA
Curation and Informatics Component
$275,086Marko E Horb · Marine Biological Laboratory · P40 · FY2025 · OD
Enhanced CRISPR gene editing in pluripotent stem cells using carbon nanotube arrays
$275,045Ian M Dickerson · Advanced Gene Transfer Company, Inc. · R41 · FY2023 · GM
Collaborative Research: EDGE FGT: Genome-wide knock-out mutant libraries for the microcrustacean Daphnia
$275,000Sen Xu · University Of Texas At Arlington · · FY2022 · BIO
Cancer Center Administration
$274,981David M Gosky · Ohio State University · P30 · FY2025 · CA